Beta-agonist carbostyril derivatives, assay method and pharmacol

Details Beta-agonist carbostyril derivatives, assay method and pharmacol Beta-agonist carbostyril derivatives, assay method and pharmacol

1988-03-29

1990-01-16

Maples, John S.

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

Magnetic imaging agent

546157, 514312, 424 11, A61K 4900, A61K 3147, C07D21520

Patent

active

048942197

ABSTRACT:
Beta-agonist carbostyril derivatives having the formula ##STR1## wherein X may be the ortho, meta or para position and is selected from the group consisting of halogen, amino and substituted and unsubstituted lower alkanoylamino having from 1 to 6 carbon atoms and pharmaceutically acceptable salts and complexes thereof.

REFERENCES:
patent: 4223137 (1980-09-01), Yoshizaki et al.
patent: 4687776 (1987-08-01), Chow et al.
Milecki et al., "Carbostyril Derivatives Having Potent B-Adrenergic Agonist Properties", J. Med. Chem., 30, 9/1987, pp. 1563-1566.

Affiliated with

Also associated with

Rating

Beta-agonist carbostyril derivatives, assay method and pharmacol does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Beta-agonist carbostyril derivatives, assay method and pharmacol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Beta-agonist carbostyril derivatives, assay method and pharmacol will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1333831